PharmaSGP Holding Balance Sheet Health
Financial Health criteria checks 5/6
PharmaSGP Holding has a total shareholder equity of €44.7M and total debt of €73.2M, which brings its debt-to-equity ratio to 163.9%. Its total assets and total liabilities are €140.9M and €96.3M respectively. PharmaSGP Holding's EBIT is €26.3M making its interest coverage ratio 7.4. It has cash and short-term investments of €46.3M.
Key information
163.9%
Debt to equity ratio
€73.21m
Debt
| Interest coverage ratio | 7.4x |
| Cash | €46.27m |
| Equity | €44.67m |
| Total liabilities | €96.26m |
| Total assets | €140.93m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: PSGD's short term assets (€73.9M) exceed its short term liabilities (€29.2M).
Long Term Liabilities: PSGD's short term assets (€73.9M) exceed its long term liabilities (€67.1M).
Debt to Equity History and Analysis
Debt Level: PSGD's net debt to equity ratio (60.3%) is considered high.
Reducing Debt: PSGD had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Debt Coverage: PSGD's debt is well covered by operating cash flow (37.8%).
Interest Coverage: PSGD's interest payments on its debt are well covered by EBIT (7.4x coverage).